Article Information
History
- July 18, 2020.
Article Versions
- You are currently viewing Version 1 of this article (July 18, 2020 - 16:25).
- Version 2 (August 24, 2020 - 16:55).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Aubin Moutal1,
- Laurent F. Martin2,†,
- Lisa Boinon1,†,
- Kimberly Gomez1,†,
- Dongzhi Ran1,†,
- Yuan Zhou1,†,
- Harrison J. Stratton1,
- Song Cai1,
- Shizhen Luo1,
- Kerry Beth Gonzalez1,
- Samantha Perez-Miller1,2,
- Amol Patwardhan1,2,4,
- Mohab M. Ibrahim1,2,4 and
- Rajesh Khanna1,2,3,4,*
- 1Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona, 85724 United States of America
- 2Department of Anesthesiology, College of Medicine, The University of Arizona, Tucson, Arizona, 85724 United States of America
- 3Center for Innovation in Brain Sciences, University of Arizona, Tucson, Arizona 85721, United States of America
- 4Comprehensive Pain and Addiction Center, The University of Arizona, Tucson, Arizona, 85724 United States of America
- ↵*Correspondence to: Dr. Rajesh Khanna, Department of Pharmacology, College of Medicine, University of Arizona, 1501 North Campbell Drive, P.O. Box 245050, Tucson, AZ 85724, USA Office phone: (520) 626-4281; Fax: (520) 626-2204; Email: rkhanna{at}arizona.edu
↵† Contributed equally
Posted July 18, 2020.
SARS-CoV-2 Spike protein hijacks VEGF-A/Neuropilin-1 receptor signaling to induce analgesia
